Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **Vibrio cholerae O1 antigen**, also known as the lipopolysaccharide (LPS) O-specific polysaccharide, is a carbohydrate structure located on the outer membrane surface of *Vibrio cholerae* strains belonging to serogroup O1—the primary cause of epidemic/pandemic human cholera worldwide[2][4]. The structure consists mainly of repeating perosamine-containing oligosaccharides that define two main serotypes—Ogawa and Inaba—based on subtle chemical differences such as methylation patterns at terminal residues[5][7]. This surface-exposed molecule serves several key roles:\n\n> \"The *Vibrio cholerae* lipopolysaccharide O1 antigen is a major target of bacteriophages and the human immune system... [and] is critical for infectivity\"[1].\n\nIt acts as an essential virulence factor required for colonization/infection; it also functions as a receptor for certain lytic bacteriophages that specifically bind these structures during infection cycles.[3] The high immunogenicity makes it central in current vaccine formulations aiming to elicit protective antibodies capable of neutralizing diverse clinical isolates.[7] However, phase-variable expression controlled by genes such as manA/wbeL allows bacterial populations flexibility under selective pressure from host immunity or phage predation.[1]\n\nIn summary, **Vibrio cholerae O1 antigen/LPS-O-SP is an essential bacterial surface carbohydrate serving both pathogenicity/immune evasion functions—and remains one of microbiology’s best-characterized targets for diagnostics, therapeutics, phage therapy research, and rational vaccine design.
For drugs/vaccines targeting this molecule:\n- Induction of protective antibody responses that recognize and neutralize V. cholerae by binding to its surface-exposed LPS/O-antigen, blocking colonization or promoting opsonophagocytosis[7].\nFor phages:\n- Adsorption/attachment via specific recognition of the O-antigen as a cell-surface receptor, leading to infection/lysis of bacteria[3].
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vibrio cholerae O1 antigen.